Predictive value positive of MTM eligibility criteria under MMA and ACA in identifying individuals with medication utilization issues-Reference-Cited by-同舟云学术

Predictive value positive of MTM eligibility criteria under MMA and ACA in identifying individuals with medication utilization issues

Published:2018-09-07 Issue:4 Volume:9 Page:393-401
ISSN:1759-8885
Container-title:Journal of Pharmaceutical Health Services Research
language:en
Short-container-title:J Pharm Health Serv Res

Author:

Qiao Yanru¹,Spivey Christina A.²,Wang Junling¹^ORCID,Shih Ya-Chen Tina³,Wan Jim Y.⁴,Kuhle Julie⁵,Dagogo-Jack Samuel⁶,Cushman William C.⁷,Chisholm-Burns Marie⁸

Affiliation:

1. Health Outcomes and Policy Research; Department of Clinical Pharmacy & Translational Science; University of Tennessee College of Pharmacy; Memphis TN USA

2. Department of Clinical Pharmacy & Translational Science; University of Tennessee College of Pharmacy; Memphis TN USA

3. Department of Health Services Research; Section of Cancer Economics and Policy; The University of Texas MD Anderson Cancer Center; Houston TX USA

4. Department of Preventive Medicine; University of Tennessee Health Science Center; Memphis TN USA

5. Measure Operations; Pharmacy Quality Alliance; Alexandria VA USA

6. Division of Endocrinology; Diabetes & Metabolism; Clinical Research Center; University of Tennessee Health Science Center; Memphis TN USA

7. Department of Preventive Medicine; Veterans Affairs Medical Center; Memphis TN USA

8. University of Tennessee College of Pharmacy; Memphis TN USA

Funder

National Institute on Aging

Publisher

Oxford University Press (OUP)

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jphs.12266/fullpdf

Reference43 articles.

1. Aitken M Valkova S Avoidable costs in U.S. healthcare: the $200 billion opportunity from using medicines more responsibly 2013 http://www.drugstorenews.com/sites/drugstorenews.com/files/Avoidable%20Costs%20in%20Healthcare.pdf http://www.webcitation.org/6fatM9xnn

2. Hospitalizations caused by adverse drug reactions (ADR): a meta-analysis of observational studies;Beijer;Pharm World Sci,2002

3. Medicare Program; Medicare prescription drug benefit. Final Rule;Centers for Medicare and Medicaid Services (CMS), Department of Health and Human Services.;Fed Regist,2005

4. Medication Therapy Management in community pharmacy practice: core elements of an MTM service (Version 1.0);American Pharmacists Association and National Association of Chain Drug Stores Foundation;J Am Pharm Assoc (2003),2005

5. Definition of Medication Therapy Management: development of professionwide consensus;Bluml;J Am Pharm Assoc (2003),2005

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a New Synthetic Route of the Key Intermediate of Irbesartan;Organic Process Research & Development;2022-08-04